Gemcitabine Plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Breast Cancer Patients
- 11 June 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (11) , 2245-2249
- https://doi.org/10.1200/jco.2000.18.11.2245
Abstract
PURPOSE: To determine the safety and efficacy of gemcitabine plus cisplatin for patients with relapsed adenocarcinoma of the breast. PATIENTS AND METHODS: Previously treated patients with adenocarc...Keywords
This publication has 13 references indexed in Scilit:
- Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancerAnti-Cancer Drugs, 1999
- Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapyCancer Treatment Reviews, 1998
- The role of gemcitabine in the treatment of other tumoursBritish Journal of Cancer, 1998
- Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemiasCancer Chemotherapy and Pharmacology, 1996
- Clinical, toxicological and pharmacological aspects of gemcitabineCancer Treatment Reviews, 1996
- Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenograftsEuropean Journal Of Cancer, 1995
- Advanced breast cancer: a phase II trial with gemcitabine.Journal of Clinical Oncology, 1995
- The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancerBritish Journal of Cancer, 1993
- 2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasmsBritish Journal of Cancer, 1993